Adjuvant intra-arterial 5-fluoruracil, leucovorin, epirubicin and carboplatin with or without systemic gemcitabine after curative resection for pancreatic adenocarcinoma.

MLA

Cantore, Maurizio, et al. “Adjuvant Intra-Arterial 5-Fluoruracil, Leucovorin, Epirubicin and Carboplatin with or without Systemic Gemcitabine after Curative Resection for Pancreatic Adenocarcinoma.” Cancer Chemotherapy and Pharmacology, vol. 58, no. 4, Oct. 2006, pp. 504–08. EBSCOhost, https://doi.org/10.1007/s00280-006-0200-2.

APA

Cantore, M., Serio, G., Pederzoli, P., Mambrini, A., Iacono, C., Pulica, C., Capelli, P., Lombardi, M., Torri, T., Pacetti, P., Pagani, M., & Fiorentini, G. (2006). Adjuvant intra-arterial 5-fluoruracil, leucovorin, epirubicin and carboplatin with or without systemic gemcitabine after curative resection for pancreatic adenocarcinoma. Cancer Chemotherapy and Pharmacology, 58(4), 504–508. https://doi.org/10.1007/s00280-006-0200-2

Chicago

Cantore, Maurizio, Giovanni Serio, Paolo Pederzoli, Andrea Mambrini, Calogero Iacono, Coriolano Pulica, Paola Capelli, et al. 2006. “Adjuvant Intra-Arterial 5-Fluoruracil, Leucovorin, Epirubicin and Carboplatin with or without Systemic Gemcitabine after Curative Resection for Pancreatic Adenocarcinoma.” Cancer Chemotherapy and Pharmacology 58 (4): 504–8. doi:10.1007/s00280-006-0200-2.